Feb 09, 2022 8:00 am EST Immunovant to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Feb 04, 2022 7:00 am EST Immunovant Reports Financial Results for the Quarter Ended December 31, 2021
Dec 30, 2021 7:00 am EST Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022
Nov 05, 2021 7:30 am EDT Immunovant Reports Financial Results for the Quarter Ended September 30, 2021